Vonoprazan Hp Dual or Triple Eradication Regimes
NCT05345210 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2022-10-20
Summary
To evaluate the efficacy and safety of dual or triple regimes for Helicobacter Pylori eradication using Vonoprazan as the antiacid agent.
Conditions
- Helicobacter Pylori
Interventions
- DRUG
-
Vonoprazan Fumarate+Amoxycillin+Clarithromycin 14days (VAC14)
VAC-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po, Clarithromycin 500mg bid po for 14 days VA-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po for 14 days VA-7d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po for 7 days VTF-14d:Vonoprazan Fumarate 20mg bid po, Tetracycline 500mg tid po, Furazolidone 100 bid po for 14 days VTF-7d:Vonoprazan Fumarate 20mg bid po, Tetracycline 500mg tid po, Furazolidone 100 bid po for 7 days
- DRUG
-
Vonoprazan Fumarate+Amoxycillin 14days (VA14)
VAC-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po, Clarithromycin 500mg bid po for 14 days VA-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po for 14 days VA-7d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po for 7 days VTF-14d:Vonoprazan Fumarate 20mg bid po, Tetracycline 500mg tid po, Furazolidone 100 bid po for 14 days VTF-7d:Vonoprazan Fumarate 20mg bid po, Tetracycline 500mg tid po, Furazolidone 100 bid po for 7 days
- DRUG
-
Vonoprazan Fumarate+Amoxycillin 7days (VA7)
VAC-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po, Clarithromycin 500mg bid po for 14 days VA-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po for 14 days VA-7d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po for 7 days VTF-14d:Vonoprazan Fumarate 20mg bid po, Tetracycline 500mg tid po, Furazolidone 100 bid po for 14 days VTF-7d:Vonoprazan Fumarate 20mg bid po, Tetracycline 500mg tid po, Furazolidone 100 bid po for 7 days
- DRUG
-
Vonoprazan Fumarate+Tetracycline+Furazolidone 14days (VTF14)
VAC-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po, Clarithromycin 500mg bid po for 14 days VA-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po for 14 days VA-7d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po for 7 days VTF-14d:Vonoprazan Fumarate 20mg bid po, Tetracycline 500mg tid po, Furazolidone 100 bid po for 14 days VTF-7d:Vonoprazan Fumarate 20mg bid po, Tetracycline 500mg tid po, Furazolidone 100 bid po for 7 days
- DRUG
-
Vonoprazan Fumarate+Tetracycline+Furazolidone 7days (VTF7)
VAC-14d:Vonoprazan Fumarate 20mg bid po, Amoxycillin 1000mg bid po, Clarithromycin 500mg bid po for 14 days
Sponsors & Collaborators
-
Xijing Hospital of Digestive Diseases
lead OTHER
Principal Investigators
-
Ying Han · Xijing Hosipital of Digestive Disease
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-25
- Primary Completion
- 2023-02-28
- Completion
- 2023-03-31
Countries
- China
Study Locations
More Related Trials
-
Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
NCT05014334 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
NCT04167670 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection
NCT07275827 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis
NCT03908619 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
NCT04728516 ·Status: RECRUITING ·Phase: PHASE4
-
VA Dual Sequential Therapy
NCT06929962 ·Status: RECRUITING ·Phase: PHASE4
-
Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection
NCT07040839 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Vonoprazan for Helicobacter Pylori Eradication in Adolescents
NCT06162949 ·Status: COMPLETED ·Phase: PHASE3
-
Tegoprazan- Versus PPI-based H. Pylori Eradication
NCT06682533 ·Status: RECRUITING
-
Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication
NCT06101420 ·Status: COMPLETED ·Phase: PHASE3
-
Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy
NCT02296021 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control
NCT00713947 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic Hemostasis
NCT05005910 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding
NCT06783257 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
NCT06660342 ·Status: RECRUITING
-
Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)
NCT02743949 ·Status: COMPLETED ·Phase: PHASE2
-
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
NCT05582174 ·Status: RECRUITING ·Phase: PHASE4
-
Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients
NCT05933031 ·Status: UNKNOWN ·Phase: PHASE2
-
AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers
NCT00325715 ·Status: COMPLETED ·Phase: PHASE1
-
Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)
NCT05647278 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment
NCT02084420 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks
NCT06953986 ·Status: RECRUITING ·Phase: NA
-
The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships
NCT00162877 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori
NCT02767479 ·Status: COMPLETED ·Phase: PHASE3
-
Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety
NCT02679508 ·Status: COMPLETED ·Phase: PHASE4